Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor

Human Molecular Genetics

Volumn 12, Issue 13, 2003, Pages 1497-1506

  Mandrusiak, Lisa M ^a,b   Beitel, Lenore K ^a,b   Wang, Xiaoling ^c   Scanlon, Thomas C ^a,b   Chevalier Larsen, Erica ^d   Merry, Diane E ^d   Trifiro, Mark A ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; AMINE; ANDROGEN RECEPTOR; ANTIBODY; CYSTAMINE; CYTOSINE; EPITOPE; GLUTAMINE; GREEN FLUORESCENT PROTEIN; GUANINE; LIGAND; LYSINE; POLYGLUTAMINE; PROTEASOME; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UBIQUITIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; CELL ACTIVITY; CELL DEATH; CONTROLLED STUDY; CROSS LINKING; DEGENERATIVE DISEASE; DISEASE COURSE; ENZYME MECHANISM; HUMAN; HUMAN CELL; HYPOTHESIS; INCUBATION TIME; KENNEDY DISEASE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; TRANSGENIC MOUSE; TRINUCLEOTIDE REPEAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN; CELL DEATH; CELL LINE; CROSS-LINKING REAGENTS; CYSTAMINE; CYSTEINE ENDOPEPTIDASES; EPITOPES; GLUTAMINE; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; LUMINESCENT PROTEINS; LYSINE; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; MULTIENZYME COMPLEXES; PEPTIDES; PLASMIDS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANDROGEN; TRANSFECTION; TRANSGLUTAMINASES;

ANIMALIA; MUS MUSCULUS;

EID: 0038782130     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg161     Document Type: Review

References (48)

1. Zoghbi, H.Y. and Orr, H.T. (2000) Glutamine repeats and neurodegeneration. A. Rev. Neurosci., 23, 217-247.
2. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. and Fischbeck, K.H. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature, 352, 77-79.
3. Kennedy, W.R., Alter, M. and Sung, J.H. (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology, 18, 671-680.
4. Zajac, J.D and MacLean, H.E. (1998) Kennedy's disease: clinical aspects. In Wells, R.D and Warren, S.T. (eds), Genetic Instabilities and Hereditary Neurological Diseases. Academic Press, New York, pp. 87-100.
5. Walcott, J.L. and Merry, D.E. (2002) Trinucleotide repeat disease. The androgen receptor in spinal and bulbar muscular atrophy. Vitam. Horm., 65, 127-147.
6. Violante, V., Luongo, A., Pepe, I., Annunziata, S. and Gentile, V. (2001) Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases. Brain. Res. Bull., 56, 169-172.
7. n-expansion diseases with special reference to the role of tissue transglutaminase and to selective vulnerability. J. Neurochem., 72, 889-899.
8. Kim, S.Y., Grant, P., Lee, J.H., Pant, H.C. and Steinert, P.M. (1999) Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer's disease. J. Biol. Chem., 274, 30715-30721.
9. Lesort, M., Attanavanich, K., Zhang, J. and Johnson, G.V. (1998) Distinct nuclear localization and activity of tissue transglutaminase. J. Biol. Chem., 273, 11991-11994.
10. Bailey, C.K., Andriola, I.F., Kampinga, H.H. and Merry, D.E. (2002) Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum. Mol. Genet., 11, 515-523.
11. Cooper, A.J., Jeitner, T.M., Gentile, V. and Blass, J.P. (2002) Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)(n)/Q(n)-expansion diseases? Neurochem. Int., 40, 53-67.
12. Bence, N.F., Sampat, R.M. and Kopito, R.R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science, 292, 1552-1555.
13. Whitby, F.G., Masters, E.I., Kramer, L., Knowlton, J.R., Yao, Y., Wang, C.C. and Hill, C.P. (2000) Structural basis for the activation of 20S proteasomes by 11S regulators. Nature, 408, 115-120.
14. Grootjans, J.J., Groenen, P.J. and de Jong, W.W. (1995) Substrate requirements for transglutaminases. Influence of the amino acid residue preceding the amine donor lysine in a native protein. J. Biol. Chem., 270, 22855-22858.
15. Bennett, M.J., Huey-Tubman, K.E., Herr, A.B., West, A.P. Jr, Ross, S.A. and Bjorkman, P.J. (2002) A linear lattice model for polyglutamine in CAG-expansion diseases. Proc. Natl Acad. Sci. USA, 99, 11634-11639.
16. Gottlieb, B., Beitel, L.K., Lumbroso, R., Pinsky, L. and Trifiro, M. (1999) Update of the androgen receptor gene mutations database. Hum. Mutat., 14, 103-114.
17. Stein, R.L., Melandri, F. and Dick, L. (1996) Kinetic characterization of the chymotryptic activity of the 20S proteasome. Biochemistry, 35, 3899-3908.
18. Kahlem, P., Green, H. and Djian, P. (1998) Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. Mol. Cell., 1, 595-601.
19. Karpuj, M.V., Garren, H., Slunt, H., Price, D.L., Gusella, J., Becher, M.W. and Steinman, L. (1999) Transglutaminase aggregates huntingtin into nonamyloidogenic polymers, and its enzymatic activity increases in Huntington's disease brain nuclei. Proc. Natl Acad. Sci. USA, 96, 7388-7393.
20. Lesort, M., Chun, W., Johnson, G.V. and Ferrante, R.J. (1999) Tissue transglutaminase is increased in Huntington's disease brain. J. Neurochem., 73, 2018-2027.
21. Zainelli, G.M., Ross, C.A., Troncoso, J.C. and Muma, N.A. (2003) Transglutaminase cross-links in intranuclear inclusions in Huntington disease. J. Neuropathol. Exp. Neurol., 62, 14-24.
22. Igarashi, S., Koide, R., Shimohata, T., Yamada, M., Hayashi, Y., Takano, H., Date, H., Oyake, M., Sato, T., Sato, A. et al. (1998) Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat. Genet., 18, 111-117.
23. de Cristofaro, T., Affaitati, A., Cariello, L., Avvedimento, E.V. and Varrone, S. (1999) The length of polyglutamine tract, its level of expression, the rate of degradation, and the transglutaminase activity influence the formation of intracellular aggregates. Biochem. Biophys. Res. Commun., 260, 150-158.
24. Karpuj, M.V., Becher, M.W., Springer, J.E., Chabas, D., Youssef, S., Pedotti, R., Mitchell, D. and Steinman, L. (2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat. Med., 8, 143-149.
25. Mastroberardino, P.G., Iannicola, C., Nardacci, R., Bernassola, F., De Laurenzi, V., Melino, G., Moreno, S., Pavone, F., Oliverio, S., Fesus, L. et al. (2002) 'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease. Cell. Death. Differ., 9, 873-880.
26. Abdullah, A., Trifiro, M.A., Panet-Raymond, V., Alvarado, C., de Tourreil, S., Frankel, D., Schipper, H.M. and Pinsky, L. (1998) Spinobulbar muscular atrophy: polyglutamine-expanded androgen receptor is proteolytically resistant in vitro and processed abnormally in transfected cells. Hum. Mol. Genet., 7, 379-384.
27. Darrington, R.S., Butler, R., Leigh, P.N., McPhaul, M.J. and Gallo, J.M. (2002) Ligand-dependent aggregation of polyglutamine-expanded androgen receptor in neuronal cells. Neuroreport, 13, 2117-2120.
28. Walcott, J.L. and Merry, D.E. (2002) Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J. Biol. Chem., 277, 50855-50859.
29. Katsuno, M., Adachi, H., Kume, A., Li, M., Nakagomi, Y., Niwa, H., Sang, C., Kobayashi, Y., Doyu, M. and Sobue, G. (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron, 35, 843-854.
30. Takeyama, K., Ito, S., Yamamoto, A., Tanimoto, H., Furutani, T., Kanuka, H., Miura, M., Tabata, T. and Kato, S. (2002) Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron, 35, 855-864.
31. Yang, W., Dunlap, J.R., Andrews, R.B. and Wetzel, R. (2002) Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet., 11, 2905-2917.
32. Saudou, F., Finkbeiner, S., Devys, D. and Greenberg, M.E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell, 95, 55-66.
33. Paulson, H.L. (1999) Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold. Am. J. Hum. Genet., 64, 339-345.
34. Lee, C., Prakash, S. and Matouschek, A. (2002) Concurrent translocation of multiple polypeptide chains through the proteasomal degradation channel. J. Biol. Chem., 277, 34760-34765.
35. Hoppe, T., Matuschewski, K., Rape, M., Schlenker, S., Ulrich, H.D. and Jentsch, S. (2000) Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing. Cell, 102, 577-586.
36. Stenoien, D.L., Cummings, C.J., Adams, H.P., Mancini, M.G., Patel, K., DeMartino, G.N., Marcelli, M., Weigel, N.L. and Mancini, M.A. (1999) Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet., 8, 731-741.
37. Abel, A., Walcott, J., Woods, J., Duda J., and Merry, D. (2001) Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Hum. Mol. Gen., 10, 107-116.
38. Qiu, J.H., Asai, A., Chi, S., Saito, N., Hamada, H. and Kirino, T. (2000) Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci., 20, 259-265.
39. Melino, G. and Piacentini, M. (1998) 'Tissue' transglutaminase in cell death: a downstream or a multifunctional upstream effector? FEBS Lett., 430, 59-63.
40. Citron, B.A., Suo, Z., SantaCruz, K., Davies, P.J., Qin, F. and Festoff, B.W. (2002) Protein crosslinking, tissue transglutaminase, alternative splicing and neurodegeneration. Neurochem. Int., 40, 69-78.
41. Panov, A.V., Gutekunst, C.A., Leavitt, B.R., Hayden, M.R., Burke, J.R., Strittmatter, W.J. and Greenamyre, J.T. (2002) Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci., 5, 731-736.
42. Zhang, J., Lesort, M., Guttmann, R.P. and Johnson, G.V. (1998) Modulation of the in situ activity of tissue transglutaminase by calcium and GTP. J. Biol. Chem., 273, 2288-2295.
43. Lesort, M., Tucholski, J., Zhang, J. and Johnson, G.V. (2000) Impaired mitochondrial function results in increased tissue transglutaminase activity in situ. J. Neurochem., 75, 1951-1961.
44. Verhoef, L.G., Lindsten, K., Masucci, M.G. and Dantuma, N.P. (2002) Aggregate formation inhibits proteasomal degradation of polyglutamine proteins. Hum. Mol. Genet., 11, 2689-2700.
45. Jana, N.R., Zemskov, E.A., Wang, G. and Nukina, N. (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum. Mol. Genet., 10, 1049-1059.
46. Beitel, L.K., Elhaji, Y.A., Lumbroso, R., Wing, S.S., Panet-Raymond, V., Gottlieb, B., Pinsky, L. and Trifiro, M.A. (2002) Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity. J. Mol. Endocrinol., 29, 41-60.
47. Melino, G., Annicchiarico-Petruzzelli, M., Piredda, L., Candi, E., Gentile, V., Davies, P.J.A. and Piacentini, M. (1994) Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol. Cell. Biol., 14, 6584-6596.
48. Panet-Raymond, V., Gottlieb, B., Beitel, L.K., Schipper, H., Timiansky, M., Pinsky, L. and Trifiro, M.A. (2001) Characterization of intracellular aggregates using fluorescently-tagged polyglutamine-expanded androgen receptor. Neurotox. Res., 3, 259-275.